Target Interacting Protein Information
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T14006 | Target Info | |||
Target Name | CDK inhibitor 1B p27Kip1 (CDKN1B) | ||||
Synonyms | p27Kip1; KIP1; Cyclindependent kinase inhibitor p27; Cyclin-dependent kinase inhibitor p27; Cyclin-dependent kinase inhibitor 1B | ||||
Target Type | Literature-reported Target | ||||
Gene Name | CDKN1B | ||||
UniProt ID |
Target Interacting Proteins | Top | ||||
---|---|---|---|---|---|
Cell cycle related proteins | [+] 4 Cell cycle related proteins | + | |||
Interacting Target Name | G1/S-specific cyclin-E1 (CCNE1) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | G1/S-specific cyclin E; Cyclin E; CCNE | ||||
Evidence Score (E-score) | 6 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [1] | |||
2 | Affinity Capture-Western | [2] | |||
3 | Affinity Capture-Western | [3] | |||
4 | Affinity Capture-Western | [4] | |||
5 | Affinity Capture-Western | [5] | |||
6 | Reconstituted Complex | [6] | |||
Interacting Target Name | Cyclin D (CCND3) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | G1/S-specific cyclin-D3 | ||||
Evidence Score (E-score) | 6 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [7] | |||
2 | Affinity Capture-Western | [8] | |||
3 | Affinity Capture-Western | [9] | |||
4 | Affinity Capture-Western | [10] | |||
5 | Affinity Capture-Western | [11] | |||
6 | Reconstituted Complex | [8] | |||
Interacting Target Name | G1/S-specific cyclin-D1 (CCND1) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | PRAD1 oncogene; PRAD1; Cyclin D1; BCL-1 oncogene; BCL-1; BCL1; B-cell lymphoma 1 protein | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [4] | |||
2 | Reconstituted Complex | [8] | |||
3 | Reconstituted Complex | [6] | |||
Interacting Target Name | Cyclin A2 (CCNA2) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Cyclin-A2; Cyclin-A; Cyclin A; CCNA | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [4] | |||
2 | Reconstituted Complex | [12] | |||
3 | Reconstituted Complex | [13] | |||
Kinases | [+] 6 Kinases | + | |||
Interacting Target Name | Cyclin-dependent kinase 2 (CDK2) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | SIN3-associated protein; Sin3 associated polypeptide; P33 protein kinase; Cell division protein kinase 2; CDKN2 | ||||
Evidence Score (E-score) | 19 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [4] | |||
2 | Affinity Capture-Western | [14] | |||
3 | Affinity Capture-Western | [6] | |||
4 | Affinity Capture-Western | [15] | |||
5 | Affinity Capture-Western | [16] | |||
6 | Affinity Capture-Western | [9] | |||
7 | Affinity Capture-Western | [2] | |||
8 | Affinity Capture-Western | [17] | |||
9 | Affinity Capture-Western | [3] | |||
10 | Affinity Capture-Western | [18] | |||
11 | Affinity Capture-Western | [5] | |||
12 | Affinity Capture-Western | [19] | |||
13 | Affinity Capture-Western | [20] | |||
14 | Affinity Capture-Western | [21] | |||
15 | Affinity Capture-Western | [22] | |||
16 | Reconstituted Complex | [12] | |||
17 | Reconstituted Complex | [6] | |||
18 | Reconstituted Complex | [13] | |||
19 | Reconstituted Complex | [23] | |||
Interacting Target Name | Cyclin-dependent kinase 4 (CDK4) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | PSK-J3; Cell division protein kinase 4 | ||||
Evidence Score (E-score) | 9 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [4] | |||
2 | Affinity Capture-Western | [15] | |||
3 | Affinity Capture-Western | [16] | |||
4 | Affinity Capture-Western | [9] | |||
5 | Affinity Capture-Western | [18] | |||
6 | Affinity Capture-Western | [20] | |||
7 | Affinity Capture-Western | [22] | |||
8 | Reconstituted Complex | [8] | |||
9 | Reconstituted Complex | [6] | |||
Interacting Target Name | Cyclin-dependent kinase 6 (CDK6) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Serine/threonine-protein kinase PLSTIRE; Serine/threonine protein kinase PLSTIRE; Cell division protein kinase 6; CDKN6 | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [24] | |||
2 | Affinity Capture-Western | [25] | |||
3 | Co-localization | [26] | |||
Interacting Target Name | RAC-alpha serine/threonine-protein kinase (AKT1) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | RAC-PK-alpha; RAC; Proto-oncogene c-Akt; Protein kinase B alpha; Protein kinase B; PKB alpha; PKB | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [27] | |||
2 | Biochemical Activity | [28] | |||
3 | Co-localization | [26] | |||
Interacting Target Name | Cyclin-dependent kinase 1 (CDK1) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | P34CDC2; P34 protein kinase; CDKN1; CDC28A; CDC2 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [24] | |||
2 | Affinity Capture-Western | [25] | |||
Interacting Target Name | Cyclin-dependent kinase 5 (CDK5) | Patented-recorded Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | TPKII catalytic subunit; Tau protein kinase II catalytic subunit; Serine/threonine-protein kinase PSSALRE; Serine/threonine protein kinase PSSALRE; Proline-directed protein kinase F(A) (PDPK F(A)); Proline-directed protein kinase 33 kDa subunit; PDPK; Cyclin-dependent-like kinase 5; Cyclin-dependent kinase 5 (CDK5); Cell division protein kinase 5; CDKN5 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [24] | |||
2 | Biochemical Activity | [29] | |||
Membrane-bounded channels | [+] 1 Membrane-bounded channels | + | |||
Interacting Target Name | Exportin-1 (XPO1) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Exp1; CRM1; Chromosome region maintenance 1 protein homolog | ||||
Evidence Score (E-score) | 4 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [30] | |||
2 | Affinity Capture-Western | [2] | |||
3 | Affinity Capture-Western | [5] | |||
4 | Reconstituted Complex | [2] | |||
Peptidases | [+] 1 Peptidases | + | |||
Interacting Target Name | JUN activation domain binding protein (COPS5) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Signalosome subunit 5; SGN5; Jun activation domain-binding protein 1; JAB1; CSN5; COP9 signalosome complex subunit 5 | ||||
Evidence Score (E-score) | 7 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [31] | |||
2 | Affinity Capture-Western | [27] | |||
3 | Affinity Capture-Western | [20] | |||
4 | Affinity Capture-Western | [32] | |||
5 | Affinity Capture-Western | [33] | |||
6 | Affinity Capture-Western | [34] | |||
7 | Reconstituted Complex | [31] | |||
Other proteins | [+] 1 Other proteins | + | |||
Interacting Target Name | S-phase kinase-associated protein 2 (SKP2) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Skp2; P45skp2; FBXL1; F-box/LRR-repeat protein 1; F-box protein Skp2; Cyclin-A/CDK2-associated protein p45; Cyclin A/CDK2-associated protein p45; Cyclin A/CDK2-associated p45 | ||||
Evidence Score (E-score) | 10 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [28] | |||
2 | Affinity Capture-Western | [19] | |||
3 | Affinity Capture-Western | [21] | |||
4 | Affinity Capture-Western | [35] | |||
5 | Affinity Capture-Western | [36] | |||
6 | Affinity Capture-Western | [37] | |||
7 | Affinity Capture-Western | [38] | |||
8 | Affinity Capture-Western | [39] | |||
9 | Affinity Capture-Western | [40] | |||
10 | Protein-peptide | [41] |
References | Top | ||||
---|---|---|---|---|---|
REF 1 | Cyclin E/Cdk2 activity is controlled by different mechanisms in the G0 and G1 phases of the cell cycle. Cell Growth Differ. 1996 Oct;7(10):1283-90. | ||||
REF 2 | CRM1/Ran-mediated nuclear export of p27(Kip1) involves a nuclear export signal and links p27 export and proteolysis. Mol Biol Cell. 2003 Jan;14(1):201-13. | ||||
REF 3 | p27 phosphorylation by Src regulates inhibition of cyclin E-Cdk2. Cell. 2007 Jan 26;128(2):281-94. | ||||
REF 4 | Phosphorylation-dependent degradation of the cyclin-dependent kinase inhibitor p27. EMBO J. 1997 Sep 1;16(17):5334-44. | ||||
REF 5 | Modification of p27 with O-linked N-acetylglucosamine regulates cell proliferation in hepatocellular carcinoma. Mol Carcinog. 2017 Jan;56(1):258-271. | ||||
REF 6 | Altered p27(Kip1) phosphorylation, localization, and function in human epithelial cells resistant to transforming growth factor beta-mediated G(1) arrest. Mol Cell Biol. 2002 May;22(9):2993-3002. | ||||
REF 7 | Identification of human protein interaction domains using an ORFeome-based yeast two-hybrid fragment library. J Proteome Res. 2013 Jul 5;12(7):3181-92. | ||||
REF 8 | Cdk6-cyclin D3 complex evades inhibition by inhibitor proteins and uniquely controls cell's proliferation competence. Oncogene. 2001 Apr 12;20(16):2000-9. | ||||
REF 9 | Regulated activating Thr172 phosphorylation of cyclin-dependent kinase 4(CDK4): its relationship with cyclins and CDK "inhibitors". Mol Cell Biol. 2006 Jul;26(13):5070-85. | ||||
REF 10 | Antiproliferative function of p27kip1 is frequently inhibited in highly malignant Burkitt's lymphoma cells. Oncogene. 1999 Nov 4;18(46):6388-97. | ||||
REF 11 | Developmentally regulated expression of cyclin D3 and its potential in vivo interacting proteins during murine gametogenesis. Endocrinology. 1999 Jun;140(6):2790-800. | ||||
REF 12 | Substrate recruitment to cyclin-dependent kinase 2 by a multipurpose docking site on cyclin A. Proc Natl Acad Sci U S A. 1998 Sep 1;95(18):10453-8. | ||||
REF 13 | Cdk-inhibitory activity and stability of p27Kip1 are directly regulated by oncogenic tyrosine kinases. Cell. 2007 Jan 26;128(2):269-80. | ||||
REF 14 | Cleavage of p21Cip1/Waf1 and p27Kip1 mediates apoptosis in endothelial cells through activation of Cdk2: role of a caspase cascade. Mol Cell. 1998 Mar;1(4):553-63. | ||||
REF 15 | Growth arrest by the cyclin-dependent kinase inhibitor p27Kip1 is abrogated by c-Myc. EMBO J. 1996 Dec 2;15(23):6595-604. | ||||
REF 16 | C-terminal phosphorylation controls the stability and function of p27kip1. EMBO J. 2006 Nov 1;25(21):5159-70. | ||||
REF 17 | CDK2 is involved in the S-phase lengthening induced by glucocorticoids in normal human lymphocytes. Eur J Cell Biol. 2003 May;82(5):253-61. | ||||
REF 18 | Shp-1 mediates the antiproliferative activity of tissue inhibitor of metalloproteinase-2 in human microvascular endothelial cells. J Biol Chem. 2006 Feb 10;281(6):3711-21. | ||||
REF 19 | Tuberin binds p27 and negatively regulates its interaction with the SCF component Skp2. J Biol Chem. 2004 Nov 19;279(47):48707-15. | ||||
REF 20 | Jun activation domain-binding protein 1 negatively regulate p27 kip1 in non-Hodgkin's lymphomas. Cancer Biol Ther. 2008 Mar;7(3):460-7. | ||||
REF 21 | SUMOylation regulates p27Kip1 stability and localization in response to TGF. J Mol Cell Biol. 2016 Feb;8(1):17-30. | ||||
REF 22 | Small tyrosine kinase inhibitors interrupt EGFR signaling by interacting with erbB3 and erbB4 in glioblastoma cell lines. Exp Cell Res. 2011 Jun 10;317(10):1476-89. | ||||
REF 23 | Molecular basis for the specificity of p27 toward cyclin-dependent kinases that regulate cell division. J Mol Biol. 2005 Jun 17;349(4):764-73. | ||||
REF 24 | Architecture of the human interactome defines protein communities and disease networks. Nature. 2017 May 25;545(7655):505-509. | ||||
REF 25 | S10 phosphorylation of p27 mediates atRA induced growth arrest in ovarian carcinoma cell lines. J Cell Physiol. 2008 Nov;217(2):558-68. | ||||
REF 26 | Using an in situ proximity ligation assay to systematically profile endogenous protein-protein interactions in a pathway network. J Proteome Res. 2014 Dec 5;13(12):5339-46. | ||||
REF 27 | COPS5 inhibition arrests the proliferation and growth of serous ovarian cancer cells via the elevation of p27 level. Biochem Biophys Res Commun. 2017 Nov 4;493(1):85-93. | ||||
REF 28 | Akt-dependent phosphorylation of p27Kip1 promotes binding to 14-3-3 and cytoplasmic localization. J Biol Chem. 2002 Aug 9;277(32):28706-13. | ||||
REF 29 | Ubiquitin C-terminal hydrolase L1 (UCH-L1) acts as a novel potentiator of cyclin-dependent kinases to enhance cell proliferation independently of its hydrolase activity. J Biol Chem. 2013 May 3;288(18):12615-26. | ||||
REF 30 | Phosphorylation of p27Kip1 on serine 10 is required for its binding to CRM1 and nuclear export. J Biol Chem. 2002 Apr 26;277(17):14355-8. | ||||
REF 31 | Potential role of Jun activation domain-binding protein 1 as a negative regulator of p27kip1 in pancreatic adenocarcinoma. Cancer Res. 2006 Sep 1;66(17):8581-9. | ||||
REF 32 | Thioredoxin modulates activator protein 1 (AP-1) activity and p27Kip1 degradation through direct interaction with Jab1. Oncogene. 2004 Nov 25;23(55):8868-75. | ||||
REF 33 | Rare sugar D-allose induces specific up-regulation of TXNIP and subsequent G1 cell cycle arrest in hepatocellular carcinoma cells by stabilization of p27kip1. Int J Oncol. 2008 Feb;32(2):377-85. | ||||
REF 34 | JAB1 and phospho-Ser10 p27 expression profile determine human hepatocellular carcinoma prognosis. J Cancer Res Clin Oncol. 2014 Jun;140(6):969-78. | ||||
REF 35 | Retinoic acid stabilizes p27Kip1 in EBV-immortalized lymphoblastoid B cell lines through enhanced proteasome-dependent degradation of the p45Skp2 and Cks1 proteins. Oncogene. 2005 Apr 7;24(15):2483-94. | ||||
REF 36 | An Rb-Skp2-p27 pathway mediates acute cell cycle inhibition by Rb and is retained in a partial-penetrance Rb mutant. Mol Cell. 2004 Oct 8;16(1):47-58. | ||||
REF 37 | Damage-specific DNA binding protein 1 (DDB1) is involved in ubiquitin-mediated proteolysis of p27Kip1 in response to UV irradiation. Biochimie. 2011 May;93(5):867-75. | ||||
REF 38 | Phosphorylation of Ser72 does not regulate the ubiquitin ligase activity and subcellular localization of Skp2. Cell Cycle. 2010 Mar 1;9(5):975-9. | ||||
REF 39 | Phosphorylation of Skp2 regulated by CDK2 and Cdc14B protects it from degradation by APC(Cdh1) in G1 phase. EMBO J. 2008 Feb 20;27(4):679-91. | ||||
REF 40 | Dihydrotestosterone induces p27 degradation via direct binding with SKP2 in ovarian and breast cancer. Int J Mol Med. 2011 Jul;28(1):109-14. | ||||
REF 41 | SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27. Nat Cell Biol. 1999 Aug;1(4):193-9. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.